The global endoscopy procedures estimates market was valued at 225.3 million procedures in 2022 and is expected to grow at a compound annual growth rate (CAGR) of 1.3% from 2023 to 2030. The growing prevalence of chronic diseases increases the adoption of minimally invasive endoscopic surgeries to diagnose, treat, and prevent the internal organ complications associated with these diseases. According to the CDC’S National Center for Chronic Disease Prevention and Health Promotion (NCCDPHP) report, about 6 in 10 adults in the U.S. have a chronic disease. Moreover, the rapid progress by healthcare providers to introduce minimally invasive surgeries for better post-clinical outcomes is expected to drive the adoption of endoscopy procedures.
Furthermore, the rising preference for minimally invasive surgery over conventional methods is also expected to increase the number of endoscopic procedures. In addition, globally, the increasing number of surgeries performed is anticipated to boost the market growth over the forecast years. According to the data published in the International Journal of Surgery, over 310 million major medical procedures are performed each year in the world, out of which, about 40 to 50 million are performed in the U.S and 20 million in Europe. In addition, the growing incidence of stomach cancer, esophagus cancer, and colon cancer is anticipated to increase the volume of endoscopic surgeries over the forecast period.
Post COVID Outlook
The global endoscopy procedures estimates decreased by 46% from 2019 to 2020
The procedure is estimated to witness a y-o-y growth of approximately 1% to 2% in the next 5 years
A significant decrease in endoscopic procedure adoption has been noticed during 2020 due to the COVID-19 pandemic as compared to 2019. This can be attributed to the decrease in surgeries due to the government recommendations to cancel all elective surgical procedures
The growing number of cancer and gastrointestinal disorders and the increasing preference for minimally invasive surgeries are the major factor anticipated to accelerate the adoption of endoscopic surgeries over the forecast years.
Furthermore, the lockdowns and shutdowns in major geographic regions resulted in the shortage of healthcare professionals, thereby negatively impacting the endoscopy procedures performed in 2020
The technological advancement and increasing burden of chronic non-communicable diseases across the globe are expected to enhance the number of endoscopic procedures performed post-COVID years. For example, according to the WHO, globally, each year, about 71% of deaths occur due to non-communicable diseases
According to the Globocan report 2020, worldwide, the number of new cases of colorectum, stomach, and esophagus cancers was 1.9, 1.1, and 0.6 million, respectively. To diagnose collateral and gastric cancer, over 6 to 8 endoscopic biopsies are recommended, which is further propelling the adoption of endoscopic procedures. Furthermore, technological advancement in the endoscopic devices to obtain high-quality digestive tract images coupled with the development of new cost-effective devices will support the market growth. For example, Fujifilm launched its 10 new endoscopes in 2019 to strengthen its offering in interventional GI and interventional pulmonary endoscopy with advanced features like Ultra-Slim, compactible, and removable single-use distal end cap functionality for manual cleaning facility.
The gastroscopy application segment dominated the market in 2022 accounting for a share of 30.9%, in terms of the number of procedures. Others segment is anticipated to grow at the fastest rate during the forecast period. An increase in the number of endoscopic surgeries performed for the diagnosis of the upper digestive tract or esophagus is the major factor attributed to the highest share of this segment. Furthermore, increasing recommendations to perform repeated upper endoscopy surgeries for patients with cirrhosis of the liver are also anticipated to propel the segment growth.
In addition, gastroscopy is recommended by the physicians for diagnosis of several common symptoms, such as indigestion, abdominal pain, dysphagia, excessive vomiting, unusual burping, and so on, which, in turn, drives the growth of this segment. The increasing prevalence of digestive and swallowing disorders also accelerates the growth of the gastroscopy segment. For example, according to the National Foundation of Swallowing Disorders, about 15 million adults in the U.S suffered from swallowing difficulties.
AAsia Pacific region dominated the global estimates with the highest share of more than 42.8% in 2022. The growing prevalence of digestive tract disorders coupled with a larger population contributed to the high adoption of endoscopic procedures in this region. In addition, increasing awareness about minimally invasive surgeries and the growing number of modern healthcare facilities are the major factors anticipated to boost the adoption of endoscopic procedures in the region. The market in the North American region is expected to account for the second-highest share by 2030, in terms of the number of endoscopic procedures.
MEA region is anticipated to grow at the fastest rate during the forecast period. The presence of a large number of healthcare facilities performing endoscopic surgeries and the high adoption of minimally invasive endoscopic procedures are expected to drive the region’s growth. Moreover, the increasing prevalence of functional gastrointestinal disorders and irritable bowel syndrome is also expected to drive the region's growth. For example, according to International Foundation for Gastrointestinal Disorders Statistics Irritable bowel syndrome (IBS) is the most common among the American population, each year about 2.4 and 3.5 million visits are made by physicians for the diagnosis and treatment of irritable bowel syndrome in the U.S.
Market volume in 2023
228.6 million procedures
Volume forecast in 2030
249.5 million procedures
CAGR of 1.3% from 2023 to 2030
Base year for estimation
2016 - 2021
2023 - 2030
Volume in number of procedures and CAGR from 2023 to 2030
Volume forecast, growth factors, and trends
North America; Europe; Asia Pacific; South America; MEA
U.S.; Canada; U.K.; Germany; France; Italy; Spain; Russia; Switzerland; Denmark; Japan; China; India; Australia; New Zealand; Thailand; Indonesia; Malaysia; Vietnam; Philippines; Brazil; Argentina; Mexico; South Africa; Saudi Arabia; UAE; Kuwait; Israel; Qatar
Free report customization (equivalent up to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options
Avail customized purchase options to meet your exact research needs. Explore purchase options
This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2016 to 2030. For the purpose of this study, Grand View Research, Inc. has segmented the global endoscopy procedures estimates market report on the basis of application and region:
Application Outlook (Number of Procedures, 2016 - 2030)
Gastrointestinal (GI) Endoscopy
Regional Outlook (Number of Procedures, 2016 - 2030)
Middle East Africa
b. The global endoscopy procedures estimates market volume was estimated at 225.3 million procedures in 2022 and is expected to reach 228.6 million procedures in 2023.
b. The global endoscopy procedures estimates market is expected to grow at a compound annual growth rate of 1.3% from 2023 to 2030 to reach 249.5 million procedures by 2030.
b. Gastroscopy by application dominated the endoscopy procedures estimates with a share of 30.9% in 2022. This is attributable to an increase in endoscopic surgeries for the diagnosis of the upper digestive tract or esophagus.
b. This report doesn't require the key player's information.
b. Key factors that are driving the endoscopy procedures estimate market growth include the growing prevalence of chronic diseases increases the adoption of minimally invasive endoscopic surgeries to diagnose, treat, and prevent the internal organ complications associated with these diseases.
NEED A CUSTOM REPORT?
We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports, as well as offer affordable discounts for start-ups & universities. Contact us now
"The quality of research they have done for us has been excellent."